Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 609 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ranbaxy Laboratories launches anti-acne drug in US

Absoricais, which is licensed from Cipher Pharmaceuticals, can be given without regards to meals. Formulated using patented Lidose technology, the product’s fasted Area under the plasma/serum/blood concentration-time curve

Ranbaxy recalls Atorvastatin from US market

The company has neither revealed the reasons for the call back nor mentioned the facility from where the recalled products were manufactured. The Business Today cited Ranbaxy’s BSE

Cipla names new CEO

Saxena worked with various companies including Citicorp, The Boston Consulting Group, PepsiCo and most recently Novartis Pharma leading its global product strategy and commercialization operations. The new CEO

mRNA vaccines protect against viral infections in study

The data published by CureVac and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute, Germany, revealed that mRNA vaccines provoke long-existing and protective immunity by producing balanced

AIS unveils touch panel computers for pharma industry

The HMI thin client touch panels with stainless steel fronts are used for applications that require monitoring, controlling, displaying information, performance and functionality of machine-level operator interface in

Reckitt Benckiser to acquire Schiff Nutrition

Schiff board of directors have approved the transaction and asked their stockholders to tender their shares into Reckitt Benckiser’s previously announced cash tender offer of $42.00 per share,